JPWO2021081022A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021081022A5 JPWO2021081022A5 JP2022523672A JP2022523672A JPWO2021081022A5 JP WO2021081022 A5 JPWO2021081022 A5 JP WO2021081022A5 JP 2022523672 A JP2022523672 A JP 2022523672A JP 2022523672 A JP2022523672 A JP 2022523672A JP WO2021081022 A5 JPWO2021081022 A5 JP WO2021081022A5
- Authority
- JP
- Japan
- Prior art keywords
- htbz
- tetrabenazine
- average
- max
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924325P | 2019-10-22 | 2019-10-22 | |
| US62/924,325 | 2019-10-22 | ||
| PCT/US2020/056559 WO2021081022A1 (fr) | 2019-10-22 | 2020-10-21 | Dispositif d'administration transdermique de tétrabénazine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500606A JP2023500606A (ja) | 2023-01-10 |
| JPWO2021081022A5 true JPWO2021081022A5 (fr) | 2023-10-26 |
Family
ID=75619484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523672A Pending JP2023500606A (ja) | 2019-10-22 | 2020-10-21 | テトラベナジン経皮送達デバイス |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220362165A1 (fr) |
| EP (1) | EP4048268A4 (fr) |
| JP (1) | JP2023500606A (fr) |
| KR (1) | KR20220104705A (fr) |
| CN (1) | CN114828851A (fr) |
| AU (1) | AU2020370073A1 (fr) |
| BR (1) | BR112022007651A2 (fr) |
| CA (1) | CA3158407A1 (fr) |
| IL (1) | IL292405A (fr) |
| MX (1) | MX2022004827A (fr) |
| TW (1) | TW202128164A (fr) |
| WO (1) | WO2021081022A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4362942A1 (fr) * | 2021-06-30 | 2024-05-08 | Neurocrine Biosciences, Inc. | Valbénazine destinée à être utilisée dans le traitement de la dyskinésie due à une paralysie cérébrale |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1807033B1 (fr) * | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Dispositif d'administration transdermique de medicaments avec couche support occlusive |
| WO2006053067A2 (fr) * | 2004-11-09 | 2006-05-18 | Prestwick Pharmaceuticals, Inc. | Traitement de l'hypercinesie associant l'amantadine a un compose tetrabenazinique |
| US20120208773A1 (en) * | 2008-08-12 | 2012-08-16 | Valeant International (Barbados) Srl | Pharmaceutical compositions with tetrabenazine |
| EP2999444A4 (fr) * | 2013-05-20 | 2016-10-12 | Mylan Inc | Système thérapeutique transdermique pour dosage à libération prolongée de pramipexole dans le traitement de troubles neurologiques |
| PL3265085T3 (pl) * | 2015-03-06 | 2022-11-07 | Auspex Pharmaceuticals, Inc. | Sposoby leczenia zaburzeń związanych z nieprawidłowymi ruchami mimowolnymi |
| WO2018115001A1 (fr) * | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Système thérapeutique transdermique comportant de l'asénapine |
| GB2565049B (en) * | 2017-07-27 | 2020-06-10 | Reckitt Benckiser Health Ltd | A head assembly of a dermaplaning device |
| US20210128490A1 (en) * | 2018-04-25 | 2021-05-06 | Shinkei Therapeutics Llc | Tetrabenazine transdermal delivery device |
-
2020
- 2020-10-21 BR BR112022007651A patent/BR112022007651A2/pt unknown
- 2020-10-21 WO PCT/US2020/056559 patent/WO2021081022A1/fr unknown
- 2020-10-21 KR KR1020227016815A patent/KR20220104705A/ko active Search and Examination
- 2020-10-21 CN CN202080087425.4A patent/CN114828851A/zh active Pending
- 2020-10-21 CA CA3158407A patent/CA3158407A1/fr active Pending
- 2020-10-21 EP EP20879097.2A patent/EP4048268A4/fr active Pending
- 2020-10-21 IL IL292405A patent/IL292405A/en unknown
- 2020-10-21 US US17/770,857 patent/US20220362165A1/en active Pending
- 2020-10-21 JP JP2022523672A patent/JP2023500606A/ja active Pending
- 2020-10-21 AU AU2020370073A patent/AU2020370073A1/en active Pending
- 2020-10-21 MX MX2022004827A patent/MX2022004827A/es unknown
- 2020-10-21 TW TW109136539A patent/TW202128164A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220151949A1 (en) | Multi-Day Patch for the Transdermal Administration of Rotigotine | |
| JP7251033B2 (ja) | ドネペジル経皮送達システム | |
| US20220395469A1 (en) | Transdermal drug delivery system for ketamine | |
| US9050247B2 (en) | Pharmaceutical composition for external use | |
| US10004696B2 (en) | Compositions and methods for transdermal delivery of amphetamine | |
| EP1503743B1 (fr) | Systeme d'administration transdermique comportant deux couches adhesives superposees ayant des affinites differentes par rapport a la substance active contenue | |
| TW201420135A (zh) | 用於經皮傳遞哌醋甲酯（ｍｅｔｈｙｌｐｈｅｎｉｄａｔｅ）之組合物及方法 | |
| JP2020511523A (ja) | アセナピンおよびポリシロキサンまたはポリイソブチレンを含有する経皮治療システム | |
| TW201521715A (zh) | 穩定之經皮安非他命組合物及製造方法 | |
| EP3784237B1 (fr) | Dispositif d'administration transdermique de tétrabénazine | |
| JPWO2021081022A5 (fr) | ||
| JP2023500606A (ja) | テトラベナジン経皮送達デバイス | |
| JP2869167B2 (ja) | 徐放性貼付製剤 | |
| CN112057436A (zh) | 含有脂质的药物制剂、药物透皮贴剂及其制备方法 | |
| US20140370077A1 (en) | Transdermal drug delivery system containing fentanyl | |
| US20040081682A1 (en) | Transdermal system (tds) that contain inhibitors of phosphodiesterase lV | |
| WO2017153441A1 (fr) | Composition pour voie topique | |
| KR101964295B1 (ko) | 피부 자극이 감소된 메만틴 경피전달 시스템 | |
| KR20060136367A (ko) | Ｖｐ／ｖａ 공중합체 및 비-수성 부형제를 포함하는 경피용약학적 스프레이 제제들 |